Selected research
Market Structure
Global Formulation Development Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Formulation Development Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Formulation Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Formulation Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Formulation Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Formulation Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Formulation Development Services include Coriolis Pharma, Aurigene Pharmaceutical Services, Adragos Pharma, Ascendia Pharmaceuticals, Dalton Pharma Services, Intertek, Suven Pharma, Agno Pharma and SGS SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Formulation Development Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Formulation Development Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Formulation Development Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Formulation Development Services market size, projected growth trends, production technologies, key applications, and end-use industries.
Formulation Development Services Segment by Company
Coriolis Pharma
Aurigene Pharmaceutical Services
Adragos Pharma
Ascendia Pharmaceuticals
Dalton Pharma Services
Intertek
Suven Pharma
Agno Pharma
SGS SA
DPT Laboratories Ltd
MedPharm
Octavius Pharma
Pharmaron
CuriRx, Inc.
LGM pharma
Avivia BV
Corealis
Losan Pharma
Evonik Health Care
Lonza
Alcami
Scantox
Formulation Development Services Segment by Type
Food and Beverage Formula Development
Drug Formula Development
Cosmetic Formula Development
Health Care Product Formula Development
Others
Formulation Development Services Segment by Application
Large Enterprises
Small and Medium Enterprises
Formulation Development Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Formulation Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Formulation Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Formulation Development Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Formulation Development Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Formulation Development Services industry.
Chapter 3: Detailed analysis of Formulation Development Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Formulation Development Servicesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Food and Beverage Formula Development
- Drug Formula Development
- Cosmetic Formula Development
- Health Care Product Formula Development
- Others
Applications
- Large Enterprises
- Small and Medium Enterprises
Companies covered
- Coriolis Pharma
- Aurigene Pharmaceutical Services
- Adragos Pharma
- Ascendia Pharmaceuticals
- Dalton Pharma Services
- Intertek
- Suven Pharma
- Agno Pharma
- SGS SA
- DPT Laboratories Ltd
- MedPharm
- Octavius Pharma
- Pharmaron
- CuriRx, Inc.
- LGM pharma
- Avivia BV
- Corealis
- Losan Pharma
- Evonik Health Care
- Lonza
- Alcami
- Scantox
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Formulation Development Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Food and Beverage Formula Development
- 1.2.3 Drug Formula Development
- 1.2.4 Cosmetic Formula Development
- 1.2.5 Health Care Product Formula Development
- 1.2.6 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Formulation Development Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Large Enterprises
- 1.3.3 Small and Medium Enterprises
- 1.4 Global Market Growth Prospects
- 1.5 Global Formulation Development Services Growth Trends by Region
- 1.5.1 Global Formulation Development Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Formulation Development Services Market Size by Region (2021-2026)
- 1.5.3 Formulation Development Services Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Formulation Development Services Market Dynamics
- 2.1 Formulation Development Services Industry Trends
- 2.2 Formulation Development Services Industry Drivers
- 2.3 Formulation Development Services Industry Opportunities and Challenges
- 2.4 Formulation Development Services Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Formulation Development Services Revenue by Company (2021-2026)
- 3.2 Global Formulation Development Services Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Formulation Development Services Key Company Head office and Area Served
- 3.4 Global Formulation Development Services Company, Product Type & Application
- 3.5 Global Formulation Development Services Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Formulation Development Services Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Formulation Development Services Players Market Share by Revenue in 2025
- 3.6.3 2025 Formulation Development Services Tier 1, Tier 2, and Tier 3
4 Formulation Development Services Market by Type
- 4.1 Global Formulation Development Services Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Formulation Development Services Market Size by Type (2021-2032)
- 4.3 Global Formulation Development Services Market Size Share by Type (2021-2032)
5 Formulation Development Services Market by Application
- 5.1 Global Formulation Development Services Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Formulation Development Services Market Size by Application (2021-2032)
- 5.3 Global Formulation Development Services Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Coriolis Pharma
- 6.1.1 Coriolis Pharma Company Information
- 6.1.2 Coriolis Pharma Business Overview
- 6.1.3 Coriolis Pharma Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Coriolis Pharma Formulation Development Services Product Portfolio
- 6.1.5 Coriolis Pharma Recent Developments
- 6.2 Aurigene Pharmaceutical Services
- 6.2.1 Aurigene Pharmaceutical Services Company Information
- 6.2.2 Aurigene Pharmaceutical Services Business Overview
- 6.2.3 Aurigene Pharmaceutical Services Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Aurigene Pharmaceutical Services Formulation Development Services Product Portfolio
- 6.2.5 Aurigene Pharmaceutical Services Recent Developments
- 6.3 Adragos Pharma
- 6.3.1 Adragos Pharma Company Information
- 6.3.2 Adragos Pharma Business Overview
- 6.3.3 Adragos Pharma Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Adragos Pharma Formulation Development Services Product Portfolio
- 6.3.5 Adragos Pharma Recent Developments
- 6.4 Ascendia Pharmaceuticals
- 6.4.1 Ascendia Pharmaceuticals Company Information
- 6.4.2 Ascendia Pharmaceuticals Business Overview
- 6.4.3 Ascendia Pharmaceuticals Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Ascendia Pharmaceuticals Formulation Development Services Product Portfolio
- 6.4.5 Ascendia Pharmaceuticals Recent Developments
- 6.5 Dalton Pharma Services
- 6.5.1 Dalton Pharma Services Company Information
- 6.5.2 Dalton Pharma Services Business Overview
- 6.5.3 Dalton Pharma Services Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Dalton Pharma Services Formulation Development Services Product Portfolio
- 6.5.5 Dalton Pharma Services Recent Developments
- 6.6 Intertek
- 6.6.1 Intertek Company Information
- 6.6.2 Intertek Business Overview
- 6.6.3 Intertek Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Intertek Formulation Development Services Product Portfolio
- 6.6.5 Intertek Recent Developments
- 6.7 Suven Pharma
- 6.7.1 Suven Pharma Company Information
- 6.7.2 Suven Pharma Business Overview
- 6.7.3 Suven Pharma Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Suven Pharma Formulation Development Services Product Portfolio
- 6.7.5 Suven Pharma Recent Developments
- 6.8 Agno Pharma
- 6.8.1 Agno Pharma Company Information
- 6.8.2 Agno Pharma Business Overview
- 6.8.3 Agno Pharma Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Agno Pharma Formulation Development Services Product Portfolio
- 6.8.5 Agno Pharma Recent Developments
- 6.9 SGS SA
- 6.9.1 SGS SA Company Information
- 6.9.2 SGS SA Business Overview
- 6.9.3 SGS SA Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 SGS SA Formulation Development Services Product Portfolio
- 6.9.5 SGS SA Recent Developments
- 6.10 DPT Laboratories Ltd
- 6.10.1 DPT Laboratories Ltd Company Information
- 6.10.2 DPT Laboratories Ltd Business Overview
- 6.10.3 DPT Laboratories Ltd Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 DPT Laboratories Ltd Formulation Development Services Product Portfolio
- 6.10.5 DPT Laboratories Ltd Recent Developments
- 6.11 MedPharm
- 6.11.1 MedPharm Company Information
- 6.11.2 MedPharm Business Overview
- 6.11.3 MedPharm Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 MedPharm Formulation Development Services Product Portfolio
- 6.11.5 MedPharm Recent Developments
- 6.12 Octavius Pharma
- 6.12.1 Octavius Pharma Company Information
- 6.12.2 Octavius Pharma Business Overview
- 6.12.3 Octavius Pharma Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Octavius Pharma Formulation Development Services Product Portfolio
- 6.12.5 Octavius Pharma Recent Developments
- 6.13 Pharmaron
- 6.13.1 Pharmaron Company Information
- 6.13.2 Pharmaron Business Overview
- 6.13.3 Pharmaron Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Pharmaron Formulation Development Services Product Portfolio
- 6.13.5 Pharmaron Recent Developments
- 6.14 CuriRx, Inc.
- 6.14.1 CuriRx, Inc. Company Information
- 6.14.2 CuriRx, Inc. Business Overview
- 6.14.3 CuriRx, Inc. Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 CuriRx, Inc. Formulation Development Services Product Portfolio
- 6.14.5 CuriRx, Inc. Recent Developments
- 6.15 LGM pharma
- 6.15.1 LGM pharma Company Information
- 6.15.2 LGM pharma Business Overview
- 6.15.3 LGM pharma Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 LGM pharma Formulation Development Services Product Portfolio
- 6.15.5 LGM pharma Recent Developments
- 6.16 Avivia BV
- 6.16.1 Avivia BV Company Information
- 6.16.2 Avivia BV Business Overview
- 6.16.3 Avivia BV Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Avivia BV Formulation Development Services Product Portfolio
- 6.16.5 Avivia BV Recent Developments
- 6.17 Corealis
- 6.17.1 Corealis Company Information
- 6.17.2 Corealis Business Overview
- 6.17.3 Corealis Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Corealis Formulation Development Services Product Portfolio
- 6.17.5 Corealis Recent Developments
- 6.18 Losan Pharma
- 6.18.1 Losan Pharma Company Information
- 6.18.2 Losan Pharma Business Overview
- 6.18.3 Losan Pharma Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Losan Pharma Formulation Development Services Product Portfolio
- 6.18.5 Losan Pharma Recent Developments
- 6.19 Evonik Health Care
- 6.19.1 Evonik Health Care Company Information
- 6.19.2 Evonik Health Care Business Overview
- 6.19.3 Evonik Health Care Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Evonik Health Care Formulation Development Services Product Portfolio
- 6.19.5 Evonik Health Care Recent Developments
- 6.20 Lonza
- 6.20.1 Lonza Company Information
- 6.20.2 Lonza Business Overview
- 6.20.3 Lonza Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Lonza Formulation Development Services Product Portfolio
- 6.20.5 Lonza Recent Developments
- 6.21 Alcami
- 6.21.1 Alcami Company Information
- 6.21.2 Alcami Business Overview
- 6.21.3 Alcami Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.21.4 Alcami Formulation Development Services Product Portfolio
- 6.21.5 Alcami Recent Developments
- 6.22 Scantox
- 6.22.1 Scantox Company Information
- 6.22.2 Scantox Business Overview
- 6.22.3 Scantox Formulation Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.22.4 Scantox Formulation Development Services Product Portfolio
- 6.22.5 Scantox Recent Developments
7 North America
- 7.1 North America Formulation Development Services Market Size (2021-2032)
- 7.2 North America Formulation Development Services Market Size by Type
- 7.2.1 North America Formulation Development Services Market Size by Type (2021-2026)
- 7.2.2 North America Formulation Development Services Market Size by Type (2027-2032)
- 7.2.3 North America Formulation Development Services Market Share by Type (2021-2032)
- 7.3 North America Formulation Development Services Market Size by Application
- 7.3.1 North America Formulation Development Services Market Size by Application (2021-2026)
- 7.3.2 North America Formulation Development Services Market Size by Application (2027-2032)
- 7.3.3 North America Formulation Development Services Market Share by Application (2021-2032)
- 7.4 North America Formulation Development Services Market Size by Country
- 7.4.1 North America Formulation Development Services Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Formulation Development Services Market Size by Country (2021-2026)
- 7.4.3 North America Formulation Development Services Market Size by Country (2027-2032)
- 7.4.4 North America Formulation Development Services Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Formulation Development Services Market Size (2021-2032)
- 8.2 Europe Formulation Development Services Market Size by Type
- 8.2.1 Europe Formulation Development Services Market Size by Type (2021-2026)
- 8.2.2 Europe Formulation Development Services Market Size by Type (2027-2032)
- 8.2.3 Europe Formulation Development Services Market Share by Type (2021-2032)
- 8.3 Europe Formulation Development Services Market Size by Application
- 8.3.1 Europe Formulation Development Services Market Size by Application (2021-2026)
- 8.3.2 Europe Formulation Development Services Market Size by Application (2027-2032)
- 8.3.3 Europe Formulation Development Services Market Share by Application (2021-2032)
- 8.4 Europe Formulation Development Services Market Size by Country
- 8.4.1 Europe Formulation Development Services Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Formulation Development Services Market Size by Country (2021-2026)
- 8.4.3 Europe Formulation Development Services Market Size by Country (2027-2032)
- 8.4.4 Europe Formulation Development Services Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Formulation Development Services Market Size (2021-2032)
- 9.2 China Formulation Development Services Market Size by Type
- 9.2.1 China Formulation Development Services Market Size by Type (2021-2026)
- 9.2.2 China Formulation Development Services Market Size by Type (2027-2032)
- 9.2.3 China Formulation Development Services Market Share by Type (2021-2032)
- 9.3 China Formulation Development Services Market Size by Application
- 9.3.1 China Formulation Development Services Market Size by Application (2021-2026)
- 9.3.2 China Formulation Development Services Market Size by Application (2027-2032)
- 9.3.3 China Formulation Development Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Formulation Development Services Market Size (2021-2032)
- 10.2 Asia Formulation Development Services Market Size by Type
- 10.2.1 Asia Formulation Development Services Market Size by Type (2021-2026)
- 10.2.2 Asia Formulation Development Services Market Size by Type (2027-2032)
- 10.2.3 Asia Formulation Development Services Market Share by Type (2021-2032)
- 10.3 Asia Formulation Development Services Market Size by Application
- 10.3.1 Asia Formulation Development Services Market Size by Application (2021-2026)
- 10.3.2 Asia Formulation Development Services Market Size by Application (2027-2032)
- 10.3.3 Asia Formulation Development Services Market Share by Application (2021-2032)
- 10.4 Asia Formulation Development Services Market Size by Country
- 10.4.1 Asia Formulation Development Services Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Formulation Development Services Market Size by Country (2021-2026)
- 10.4.3 Asia Formulation Development Services Market Size by Country (2027-2032)
- 10.4.4 Asia Formulation Development Services Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Formulation Development Services Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Formulation Development Services Market Size by Type
- 11.2.1 South America, Middle East & Africa Formulation Development Services Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Formulation Development Services Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Formulation Development Services Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Formulation Development Services Market Size by Application
- 11.3.1 South America, Middle East & Africa Formulation Development Services Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Formulation Development Services Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Formulation Development Services Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Formulation Development Services Market Size by Country
- 11.4.1 South America, Middle East & Africa Formulation Development Services Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Formulation Development Services Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Formulation Development Services Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Formulation Development Services Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst